Author:
Lee Jun Nyung,Chun So Young,Ha Yun-Sok,Choi Kyung Hee,Yoon Ghil Suk,Kim Hyun Tae,Kim Tae-Hwan,Yoo Eun Sang,Kim Bup Wan,Kwon Tae Gyun
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Medicine (miscellaneous)
Reference40 articles.
1. Di Lorenzo G, Autorino R, Sternberg CN. Metastatic renal cell carcinoma: recent advances in the targeted therapy era. Eur Urol 2009;56:959–971.
2. Hutson TE. Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence. Oncologist 2011;16 Suppl 2:14–22.
3. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:3584–3590.
4. Park JW, Kerbel RS, Kelloff GJ, Barrett JC, Chabner BA, Parkinson DR, et al. Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development. Clin Cancer Res 2004;10:3885–3896.
5. Taneja SS. Re: molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. J Urol 2011;185:1224.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献